Non-invasive fetal RHD genotyping in the first trimester of pregnancy

@inproceedings{Cardo2010NoninvasiveFR,
  title={Non-invasive fetal RHD genotyping in the first trimester of pregnancy},
  author={L. Cardo and B. Garc{\'i}a and F. {\'A}lvarez},
  booktitle={Clinical chemistry and laboratory medicine},
  year={2010}
}
  • L. Cardo, B. García, F. Álvarez
  • Published in
    Clinical chemistry and…
    2010
  • Medicine
  • Abstract Background: Hemolytic disease of the fetus and newborn (HDN) is caused primarily by feto-maternal RhD incompatibility. Although all RhD negative pregnant women undergo routine antenatal RhD prophylaxis at 28 weeks of gestation, and following delivery if the newborn is RhD positive, HDN has not been eradicated. Here, we investigated fetal Rhesus D (RHD) genotype in maternal plasma during the first trimester of pregnancy in our area. Methods: Plasma samples were obtained from 111 RhD… CONTINUE READING
    Fetal RHD and RHCE Genotyping in Plasma of Rh Negative Pregnant Women
    • 5
    • Highly Influenced
    • PDF
    Noninvasive fetal RhD genotyping.
    • 26
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 40 REFERENCES
    Fetal RHD genotyping in maternal serum during the first trimester of pregnancy
    • 91
    Fetal DNA in maternal serum: does it persist after pregnancy?
    • 42
    Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.
    • 1,505
    • PDF
    Presence of fetal DNA in maternal plasma decades after pregnancy
    • 71